Results

Total Results: 2,064 records

Showing results for "year".

201. Weight-Gain-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
     January 01, 2020 - Although the average weight gained per year is 0.5 to 1 kg, the modest accumulation of weight over … Observational studies that followed weight change by these strategies over at least one year were also … The timepoints of interest for data abstraction of weight outcomes were at 1 year, 2 years, 5 years … Outcomes and timing One year of observation of weight change during adulthood was required. … We suggest that 1 year should be a minimum duration of followup for these interventions.

202. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
     November 26, 2024 - The following data will be abstracted • Study identifier (author) and publication year • Study design … ((((abstract: (addiction)))))))) AND (((((title: (ADHD))))) OR ((((abstract: (ADHD))))))))) AND ((Year … ("Polydrug Abuse")))) OR (((title: (polysubstance)))) OR (((abstract: (polysubstance)))))) AND ((Year … consequence)) OR (abstract: (consequences)) OR (abstract: (sequala)) OR (abstract: (sequalae))))) AND ((Year

203. Treating Infantile Hemangiomas in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_consumer.pdf
     June 01, 2016 - IH may grow very quickly in the first few months of life and may continue to grow until around 1 year

204. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
     April 23, 2019 - designed or pow ered to assess differences in fracture rates.2 The study w as initially designed as a 2-year … 282 patients evaluated with DXA and treated with bisphosphonates or denosumab during the previous year

205. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
     February 01, 2008 - complications and incontinence were lower for patients whose surgeons performed more than 40 RPs per year … length of hospital stay was shorter in patients operated on by surgeons who performed more RPs per year … One report assessed 20-year outcomes in the United States from a cohort of 767 men with prostate cancer … Patients operated on in hospitals with fewer procedures per year had increased use of adjuvant therapy … compared with those treated in hospitals that performed more RPs per year.

206. S123 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
     October 01, 2007 - controlling for cancer stage, grade, and location; age; comor- bidity; hospital access; payer; diagnosis year … For both methods, the parameter estimates are interpreted as the change in the X-year survival rate for … of all ESBC surgeries (stage I and II) in the 50-mile radius around the patient’s residence in the year … †Patient in Anear@group if distance to radiation treatment center in year of diagnosis is less than 19 … payer (Medicaid, Medicare, Blue Cross/Blue Shield, other private, other government, self-pay), and year

207. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
     September 01, 2011 - from GERD, contributing an average incremental cost to the employer of $3,355 per employee during a 3-year … Stretta group than the control group at 6 months, but the difference was no longer significant at 1 year … effective in helping patients to decrease the use of antireflux medications in the short term (≤ 1 year … One available study reviewed (the LOTUS trial) reported 3-year interim data; that study remains ongoing … - Dropout rate for studies with 7- to 12-year followup (33 to 58%).

208. Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
     December 27, 2016 - Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma Evidence-based Practice Center Systematic Review Protocol Amendment Date(s): November 18, 2016 (Amendment Details – …

209. Evidence-Summary-Cer-197-Fractional-Exhaled-Nitric-Oxide (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-197-fractional-exhaled-nitric-oxide.pdf
     December 01, 2017 - • The role of serial FeNO measurements in children ages 0-5 year who develop illness associated with

210. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - KQ1_IgG Duration_n=3 Observational studies examining IgG Duration Author Year Title PMID Link/URL … Mild: 19 (59.3) Moderately severe: 13 (40.7) Haveri 2021 Persistence of neutralizing antibodies a year … after SARS-CoV-2 infection in humans. 34580856 Persistence of neutralizing antibodies a year after SARS-CoV … Observational studies examining antibody response in immunocompromised patients Author Year … ≤1 year after primary infection: 6,111 F/u >1 year after primary infection: 474 Unvaccinated only

211. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
     June 01, 2022 - Characteristics of included studies Author, Year Country, Study Design, Study Period Study … Results from included studies: KQ 2. 5-HT1F Author, Year, Study Design Study Setting (Outpatient … E-6 Author, Year, Study Design Study Setting (Outpatient, Inpatient, ED) Intervention(s) … Risk of bias (Cochrane ROB tool) for included randomized clinical trial studies Author, Year Overall … Long-term cardiovascular safety of lasmiditan for the acute treatment of migraine for up to one year

212. Surveillance Report: CER 30: Comparative Effectiveness of Pain Management for Hip Fracture (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain_surveillance.pdf
     July 08, 2015 - Mortality (30-day and up to 1 year postfracture) b.! Functional status c.! … indirectly associated with pharmacologic and nonpharmacologic pain management interventions up to 1 year … Mortality (30-day and up to 1 year postfracture) •! Functional status •! … Mortality (30-day and up to 1 year postfracture) b. Functional status c. … Mortality (30-day and up to 1 year postfracture) b. Functional status c.

213. Data-Points-8 Tables1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
     January 01, 2009 - Antihypertensive Drug Classes Prescribed, 2006-2009 Note: Age is calculated as of December 31 of the year … Enrollment in Medicare Parts A, B, and D and With Hypertension Diagnosis Breakdown Category Year … Enrollment in Medicare Parts A, B, and D and With Hypertension Diagnosis Breakdown Category Year … Enrollment in Medicare Parts A, B, and D and With Hypertension Diagnosis Breakdown Category Year … Antihypertensive Drugs, by Drug Class, 2006-2009 Note: Age is calculated as of December 31 of the year

214. Cancer-Ovarian-Contraceptives Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
     June 01, 2013 - chemotherapy, and radiation therapy over the past 20 years have led to improved outcomes, overall 5-year … CI = confidence interval; mo = month/months; NA = not applicable; SOE = strength of evidence; yr = year … data from the same trial as another included study; or reported duration odds ratios for only the year … BRCA = breast cancer genetic mutation; CI = confidence interval; SOE = strength of evidence; yr = year … person-years) Medium Consistent Direct Precise Low Elevated risk may be present during first year

215. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - between 1 and 6 months Intermediate outcomes - treatment duration of at least 6 months and less than 1 year … Long term outcomes - treatment duration of 1 year or more Setting Outpatient settings Source: … Data Abstraction and Data Management Data fields to be extracted will include author, year of publication

216. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
     January 01, 2024 - Study Characteristic Author, year Trial name NCT # Key Questions Study design Funding source Follow-up … NCT03526510 KQ1 RCT Private (for profit) Every 3 to 6 months during follow-up for 5 years and then once a year … hyaluronic acid, prostate volume <15 cc or >9 0cc, transurethral resection of the prostate within the past year … Valeriani, 2018 NA NA KQ5 NRSI NR 2 months after the end of therapy, then every 2-3 months for the first year

217. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
     January 01, 2007 - on leflunomide met the American College of Rheumatology (ACR) 20-percent improvement criteria at 1 year … For leflunomide vs. sulfasalazine, data are limited to one RCT with 2-year followup that reported that … In the meta-analysis, 2- year withdrawals attributed to adverse events were not significantly different … Results from a six-year observational study in southern Sweden. … inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year

218. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/protocol-social-isolation.pdf
     January 01, 2013 - Data extraction categories will include author, year, country, study design, PICOs, and results.

219. Disposition of Comments_Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disposition-comments.pdf
     April 10, 2025 - LABOUR AND ENROLL THEM IN THE NEAREST GOVERNMENT SCHOOL.Government schools should be providing 0- 3 year … and 3-5 year training for optimal child development and learning .Focus 1. … day-to-day program practice assessment and not an isolated single time assessment at the end of the year … members by guiding the forces behind theri current behavior Traits fom Sates of mind rooted rom 0-5 year

220. Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
     February 05, 2025 - conditions (i.e., conditions that primarily affect the body’s systems and functions) that persist for one year … For each included trial, we will extract general study characteristics (e.g., authors, year of publication … Literature search dates The original protocol specified that the search would begin from the year … The revised protocol adjusted the starting date of the search to the year 2009. … Management For each included trial, we will extract general study characteristics (e.g., authors, year